SEC Form 5 · accession 0001209191-15-010932
Neurogene Inc. · NGNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen B Shrewsbury
Officer — CMO; Senior VP Clinical Dev.
Period of report
Dec 31, 2014
Accepted (ET)
Feb 9, 2015 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2014 | P | 400 | $8.22 | A | 400 | D |
Table II — derivative securities
No Table II lines on this filing.